BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31306912)

  • 21. Two novel fusion inhibitors of human respiratory syncytial virus.
    Lundin A; Bergström T; Bendrioua L; Kann N; Adamiak B; Trybala E
    Antiviral Res; 2010 Dec; 88(3):317-24. PubMed ID: 20965215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium.
    Mirabelli C; Jaspers M; Boon M; Jorissen M; Koukni M; Bardiot D; Chaltin P; Marchand A; Neyts J; Jochmans D
    J Antimicrob Chemother; 2018 Jul; 73(7):1823-1829. PubMed ID: 29596680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The alpha-1 subunit of the Na+,K+-ATPase (ATP1A1) is required for macropinocytic entry of respiratory syncytial virus (RSV) in human respiratory epithelial cells.
    Lingemann M; McCarty T; Liu X; Buchholz UJ; Surman S; Martin SE; Collins PL; Munir S
    PLoS Pathog; 2019 Aug; 15(8):e1007963. PubMed ID: 31381610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells.
    Zhang Y; Jamaluddin M; Wang S; Tian B; Garofalo RP; Casola A; Brasier AR
    J Virol; 2003 May; 77(10):5933-47. PubMed ID: 12719586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine
    Mackman RL; Hui HC; Perron M; Murakami E; Palmiotti C; Lee G; Stray K; Zhang L; Goyal B; Chun K; Byun D; Siegel D; Simonovich S; Du Pont V; Pitts J; Babusis D; Vijjapurapu A; Lu X; Kim C; Zhao X; Chan J; Ma B; Lye D; Vandersteen A; Wortman S; Barrett KT; Toteva M; Jordan R; Subramanian R; Bilello JP; Cihlar T
    J Med Chem; 2021 Apr; 64(8):5001-5017. PubMed ID: 33835812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential anti-respiratory syncytial virus lead compounds from Aglaia species.
    Esimone CO; Eck G; Duong TN; Uberla K; Proksch P; Grunwald T
    Pharmazie; 2008 Oct; 63(10):768-73. PubMed ID: 18972843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput screening of stabilizers for respiratory syncytial virus: identification of stabilizers and their effects on the conformational thermostability of viral particles.
    Ausar SF; Espina M; Brock J; Thyagarayapuran N; Repetto R; Khandke L; Middaugh CR
    Hum Vaccin; 2007; 3(3):94-103. PubMed ID: 17426457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prospects For the Use of Peptides against Respiratory Syncytial Virus].
    Shilovskiy IP; Andreev SM; Kozhikhova KV; Nikolskii AA; Khaitov MR
    Mol Biol (Mosk); 2019; 53(4):541-560. PubMed ID: 31397431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-Round Infectious Particle Antiviral Screening Assays for the Japanese Encephalitis Virus.
    Lu CY; Hour MJ; Wang CY; Huang SH; Mu WX; Chang YC; Lin CW
    Viruses; 2017 Apr; 9(4):. PubMed ID: 28394283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay.
    Do LAH; Tse R; Nathanielsz J; Anderson J; Ong DS; Chappell K; Mulholland K; Licciardi PV
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30741261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening and pharmacodynamic evaluation of the anti-respiratory syncytial virus activity of butene lactones in vitro and in vivo.
    Wang Z; Tan Y; Mou X; Wang C; Li Y; Xiao F; Hu X; Liu H; Xu H
    J Med Virol; 2020 Jan; 92(1):17-25. PubMed ID: 31475735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory syncytial virus: prospects for new and emerging therapeutics.
    Jorquera PA; Tripp RA
    Expert Rev Respir Med; 2017 Aug; 11(8):609-615. PubMed ID: 28574729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate.
    Deval J; Hong J; Wang G; Taylor J; Smith LK; Fung A; Stevens SK; Liu H; Jin Z; Dyatkina N; Prhavc M; Stoycheva AD; Serebryany V; Liu J; Smith DB; Tam Y; Zhang Q; Moore ML; Fearns R; Chanda SM; Blatt LM; Symons JA; Beigelman L
    PLoS Pathog; 2015 Jun; 11(6):e1004995. PubMed ID: 26098424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo evaluation of antiviral compounds on respiratory syncytial virus using a juvenile vervet monkey (Chlorocebus pygerythrus) infection model.
    Houspie L; Stevens H; Ngotho M; Keyaerts E; Ispas G; Verloes R; Van Ranst M; Maes P
    Methods Mol Biol; 2013; 1030():373-82. PubMed ID: 23821283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and characterization of a stable eGFP enterovirus 71 for antiviral screening.
    Shang B; Deng C; Ye H; Xu W; Yuan Z; Shi PY; Zhang B
    Antiviral Res; 2013 Feb; 97(2):198-205. PubMed ID: 23267829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.
    Wang KC; Chang JS; Lin LT; Chiang LC; Lin CC
    Am J Chin Med; 2012; 40(5):1033-45. PubMed ID: 22928833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques.
    Brock LG; Liu X; Liang B; Lingemann M; Liu X; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as novel dual inhibitors of respiratory syncytial virus and influenza virus A.
    Zhang GN; Li Q; Zhao J; Zhang X; Xu Z; Wang Y; Fu Y; Shan Q; Zheng Y; Wang J; Zhu M; Li Z; Cen S; He J; Wang Y
    Eur J Med Chem; 2020 Jan; 186():111861. PubMed ID: 31734025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.
    Lee BH; Chathuranga K; Uddin MB; Weeratunga P; Kim MS; Cho WK; Kim HI; Ma JY; Lee JS
    J Microbiol; 2017 Jun; 55(6):488-498. PubMed ID: 28551874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.